For In Vitro Diagnostic Use
MicroVue BAP provides a quantitative measure of bone-specific alkaline phosphatase (BAP) activity in serum. BAP is an enzyme produced by osteoblasts, the cells responsible for bone formation.
Specifications
8012 |
ELISA |
96 wells/plate |
Serum |
Intended Use
MicroVue BAP is intended for use as an aid in the:
-
management of postmenopausal osteoporosis and Paget's disease;
-
monitoring of postmenopausal women on hormonal or biophosphonate therapy;
-
prediction of skeletal response to hormonal therapy in postmenopausal women.
The Assay
Format |
96-well microplate with reagents sufficient to test 40 samples in duplicate |
Species Reactivity |
Rabbit, Pig, Dog, Sheep, Goat, Cow, Horse, Cynomolgus Monkey, Human Cell Culture. No recognition of Rat or Mouse |
Assay Steps |
- Add 125 µL Assay Buffer
- Add 20 µL Standards, Controls, and samples; swirl
- Incubate 3 hours ± 10 minutes at room temperature
- Wash 4 times with 1X Wash Buffer
- Add 150 µL room temperature Working Substrate Solution
- Incubate 30 ± 5 minutes at room temperature
- Add 100 µL Stop Solution and read OD at 405 nm
- Data Reduction: Quadratic curve |
|
Performance Characteristics
Immuno-capture |
Bone alkaline phosphatase |
Serum |
20 µL |
0.7 U/L |
2-140 U/L |
4-6% |
5-8% |
3.5 Hours |
- Bone AP 100%
- Liver AP 3-8%
- Placenta AP 0%
- Intestine AP 0.4% |
- Females 25-44 yr. premenopausal
- 11.6 - 29.6 U/L
- Females ≥ 45 yr. postmenopausal
- 14.2 - 42.7 U/L
- Males ≥ 25 yr.
- 15.0 - 41.3 U/L |
All Quidel assays are designed for laboratories equipped to perform microplate immunoassays as detailed on our Kit Format and Equipment Required page.